Daniel A. Macuga - 06 Feb 2023 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Feb 2023, 20:42:51 UTC
Prior SEC filing
07 Feb 2023
Next SEC filing
21 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joshua Foukas, Attorney-in-Fact
Filing notes and source

Key filing fact

Daniel A. Macuga filed Form 4 for USANA HEALTH SCIENCES INC (USNA) on 08 Feb 2023.

Key facts

  • This page summarizes Daniel A. Macuga's Form 4 filing for USANA HEALTH SCIENCES INC (USNA).
  • 7 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 08 Feb 2023, 20:42.

Change

  • Previous filing in this sequence was filed on 07 Feb 2023.
  • Current net transaction value: -$83,787.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

USNA transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,581
Change %
+38%
Price
Shares after
5,728
Date
07 Feb 2023
Ownership
Direct
Footnotes
F1
USNA transaction

Common Stock

Tax liability

Transaction value
-$40,039
Shares
-670
Change %
-12%
Price
$59.76
Shares after
5,058
Date
07 Feb 2023
Ownership
Direct
USNA transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,677
Change %
+33%
Price
Shares after
6,735
Date
08 Feb 2023
Ownership
Direct
Footnotes
F1
USNA transaction

Common Stock

Tax liability

Transaction value
-$43,748
Shares
-711
Change %
-11%
Price
$61.53
Shares after
6,024
Date
08 Feb 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

USNA transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+10,011
Change %
+74%
Price
$0.000000
Shares after
23,564
Date
06 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,011
Exercise price
Footnotes
F1, F2
USNA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,581
Change %
-6.7%
Price
$0.000000
Shares after
21,983
Date
07 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,581
Exercise price
Footnotes
F1, F3
USNA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,677
Change %
-7.6%
Price
$0.000000
Shares after
20,306
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,677
Exercise price
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Footnote F2

On February 6th, 2023, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.

Footnote F3

Restricted Stock Units vest 25% on the anniversary of February 7th, 2022.

Footnote F4

Restricted Stock Units vest 25% on the anniversary of February 8th, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .